|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Property and equipment, at cost less accumulated depreciation | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Deferred revenue, current portion | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Noncurrent liabilities: | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||||
| Long-term lease obligation | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total noncurrent liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $0.01 par value: Authorized shares - 20,000,000; Issued shares – 9,032,643 and 9,026,940 at June 30, 2025 and December 31, 2024, respectively; Outstanding shares – 7,792,382 and 7,786,679 at June 30, 2025 and December 31, 2024, respectively | ||||||||||||||||||||
| Treasury stock, 507,384 and 311,496 shares as of December 31, 2022 and 2021, respectively, at cost | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, 1,240,261 shares at June 30, 2025 and December 31, 2024, at cost | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
